Neurocrine Biosciences Inc (NBIX)

Current ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Total current assets US$ in thousands 1,607,000 1,649,900 1,496,600 1,432,800 1,453,500 1,205,500 1,019,300 1,018,200 972,800 1,005,700 1,110,100 1,085,400 1,016,200 1,156,900 1,146,200 968,200 831,000 819,232 748,808 633,192
Total current liabilities US$ in thousands 654,800 691,600 582,500 374,100 537,700 485,100 285,700 253,500 245,800 225,900 212,900 190,000 186,500 611,000 573,000 140,300 565,300 115,652 100,589 72,003
Current ratio 2.45 2.39 2.57 3.83 2.70 2.49 3.57 4.02 3.96 4.45 5.21 5.71 5.45 1.89 2.00 6.90 1.47 7.08 7.44 8.79

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $1,607,000K ÷ $654,800K
= 2.45

The current ratio of Neurocrine Biosciences, Inc. has displayed fluctuating trends over the past eight quarters. The ratio ranged from a low of 2.39 in Q3 2023 to a high of 4.02 in Q1 2022, indicating variability in the company's short-term liquidity position.

In general, a current ratio above 1.0 indicates that a company has more current assets than current liabilities, suggesting a strong ability to meet its short-term obligations. Neurocrine Biosciences, Inc.'s current ratio has consistently been above 1.0 across all quarters, reflecting a positive liquidity position.

The quarter with the highest current ratio was Q1 2022 at 4.02, suggesting that the company had a strong ability to cover its current liabilities with its current assets during that period. On the other hand, the lowest current ratio was observed in Q3 2023 at 2.39, implying a relatively lower liquidity position compared to other quarters.

Overall, while the current ratio of Neurocrine Biosciences, Inc. has fluctuated over the past two years, it has generally remained above 1.0, indicating a relatively healthy short-term liquidity position.


Peer comparison

Dec 31, 2023